Sponsor pipeline

Malaghan Institute of Medical Research clinical trial pipeline

2 active trials 1 recruiting 4 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-08

Primary completion pushed: 2026-06-30 → 2027-06-30
Completion pushed: 2028-06-30 → 2029-06-30

NCT06486051 A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell… · Phase 2

Phase 1		1
Phase 2		1

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT06486051	A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell…	Large B-cell Lymphoma	Recruiting	2026-08-07
Phase 1
NCT04049513	ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen…	Lymphomas Non-Hodgkin's B-Cell	Active, Not Recruiting	2024-08-21

Get alerts when Malaghan Institute of Medical Research's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.